NexusAlert Blog

SEC filing insights, market analysis, and investment research tips from the NexusAlert team.

May 26, 2026

Apogee Lands Up to $1.3B From Blackstone for Zumilokibart — Without Selling a Share

Apogee's May 27 8-K discloses up to $1.3B in non-dilutive Blackstone financing for zumilokibart: $800M synthetic royalty plus $500M senior debt. Here's how it works.

news8-kbiotechfinancingroyaltypharmaapogeeblackstone

REalloys Locks Up 15% of Tanbreez Phase 1 for 15 Years in a Greenland Rare-Earth Offtake — Six New 13F Holders Initiated Before the 8-K Hit

REalloys' May 22 8-K commits to 15% of Tanbreez Phase 1 rare-earth concentrate output for 15 years from Critical Metals' Greenland project. Six new institutional holders — Citadel, Millennium, Goldman Sachs — initiated positions in the 13F period right before the filing.

news8-kmaterial-definitive-agreementrealloyscritical-metalsrare-earthsgreenlanddefensemine-to-magnet

Amazon Just Disclosed a 65.8 Million-Share Insider Position in X-Energy on IPO Day

On April 24, 2026, Amazon filed a Form 3 disclosing 65,836,948 shares of newly public nuclear company X-Energy — a roughly 29% pre-IPO stake worth nearly $2 billion at the close. Here's what the filing reveals.

newsform-3insider-tradingipox-energyamazonnuclear

Vladimir Galkin Just Crossed 10% of JetBlue — With Margin Debt and a Board Ask on the Same 13D

Vladimir Galkin, Angelica Galkin, and the Angelica Galkin Revocable Trust disclosed a 37,200,000-share position in JetBlue — exactly 10.0% — on an April 23, 2026 SC 13D/A that names margin debt and stated intent to discuss board representation.

newssc-13dactivist-investorjetblueairlines

Wall Street Called Elevance's Q1 a 'Guidance Raise'. The 10-Q Shows a $935M Medicare Hit and 19% Net Income Decline.

Elevance Health's April 22 10-Q discloses a $935M Medicare Advantage risk-adjustment accrual that drove Q1 net income down to $1.76B from $2.18B YoY — even as the company raised 2026 adjusted EPS guidance to at least $26.75.

news10-qearningshealthcareelevancemedicare-advantage

Eli Lilly Just Killed the Second Half of Its $960M Rigel Deal — And the 8-K Says When

Rigel's April 21 8-K confirms Eli Lilly is terminating the non-CNS portion of the RIPK1 collaboration effective June 15, 2026 — the second walk-away after Lilly already dropped the CNS program in November 2025.

news8-kbiotechpartnership-terminationrigeleli-lilly

Home BancShares' Chairman & CEO Just Bought 100,000 Shares — In One Trade

Home BancShares Chairman & CEO John W. Allison filed a Form 4 disclosing an open-market purchase of 100,000 shares. NexusAlert scored it a 65 Smart Money / Strong Buy. Here's what the signal actually says.

newsform-4insider-tradinghome-bancsharesbanks

Janus Henderson Just Voted Itself Off the Public Market — 99.6% Said Yes

Janus Henderson shareholders approved the $52-per-share take-private merger with Jupiter Company by a 99.6% margin. The 8-K shows why public asset managers keep going private — and what gets missed in the headline.

mergers8-ktake-privateasset-management

B2Gold Just Disclosed a 28.83% Stake in Versamet Royalties — And Chose to File It on a 13G, Not a 13D

A publicly traded Canadian gold and silver miner disclosed a 28.83% beneficial ownership position in Versamet Royalties Corp on a Schedule 13G, crossing both the 5% and 10% thresholds in a single filing. That form choice — not the size of the stake — is the real signal. Here's what the filing actually says and how to read 13G vs 13D going forward.

sec-filingsschedule-13gb2goldversamet-royaltiesvmetroyalty-companiesinstitutional-ownership

SpaceX Just Filed the Largest S-1 in History. You Can't Read It Yet — Here's When You Can.

SpaceX confidentially submitted a draft S-1 to the SEC on April 1, 2026, targeting a potential $1.75T valuation and a $75B raise. Here's what a 'confidential' S-1 actually hides, the exact rule that forces it into the open, and how to catch it the day it lands.

sec-filingss-1ipospacexconfidential-filing

JPMorgan Just Beat Earnings. The Stock Fell Anyway. Here's What the 8-K Says.

JPMorgan posted $16.5B in Q1 profit and beat EPS estimates by nearly 10%. JPM stock still fell 0.8% on the day. The answer is buried in the 8-K — and Jamie Dimon put it plainly.

8-kearningsbankingrisk-signalsjpmorgan

Amazon Just Filed an 8-K to Buy Globalstar for $11.6B — and Quietly Took Apple's Satellite Business With It

On April 14, 2026, Amazon and Globalstar filed 8-Ks disclosing a $11.57B definitive merger agreement. Buried in the announcement: Amazon Leo will now power Apple's Emergency SOS. Here's what the filing actually says.

sec-filings8-kamzngsatm-and-amerger-agreement

Revolution Medicines Just Posted 13.2-Month OS in Phase 3 Pancreatic Cancer — Hazard Ratio 0.40. Baker Bros. Was Already at 4.9%.

On April 13, 2026, Revolution Medicines filed an 8-K reporting positive Phase 3 RASolute 302 results for daraxonrasib. $RVMD closed +41.3%. Here's what the filing actually said — and which institutions were positioned going in.

sec-filingsform-8-kclinical-trial-resultsrvmdrevolution-medicinesinstitutional-ownership